Primary Record
thalidomide
- In stock
- 9,562 g
- Purity
- 98.4 %
- CAS
- 50-35-1
Compound Identifiers & Properties
- CAS
- 50-35-1
- PubChem CID
- 5426
- SMILES
- C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
- Canonical SMILES
- O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1
Names & Synonyms
- thalidomide
- Thalomid
- Contergan
- Pantosediv
- Distaval
- Softenon
- Kevadon
- Profarmil
- Calmorex
- Neosedyn
- Quetimid
- Talimol
- Telagan
- 50-35-1
- Theophilcholine
- Corronarobetin
- Psychotablets
- Psycholiquid
- Enterosediv
- Gastrinide
- Neurosedin
- Neurosedym
- Noctosediv
- Polygripan
- Quietoplex
- Sedisperil
- Shinnibrol
- Thalinette
- Algosediv
- Ectiluran
- Nerosedyn
- Sandormin
- Telargean
- Valgraine
- Asmadion
- Bonbrain
- Glutanon
- Hippuzon
- Neosydyn
- Neurodyn
- Nevrodyn
- Sedimide
- Softenil
- Tensival
- Asmaval
- Calmore
- Grippex
- Imidene
- Noxodyn
- Sedoval
- Sleepan
- Yodomin
- Glupan
- Isomin
- Nibrol
- Pangul
- Slipro
- Thalin
- Valgis
- Sedin
- Neurosedyn
- Neaufatin
- Neufatin
- Talargan
- Talismol
- Predni-Sediv
- Imida-lab
- Poly-Giron
- Sedalis sedi-lab
- Talidomida
- Thaled
- (+/-)-THALIDOMIDE
- Ulcerfen
- Asidon 3
- Sedalis
- Shin-naito S
- Imidan (peyta)
- Pro-ban M
- N-Phthaloylglutamimide
- Thalidomidum
- Talidomide
- Thalomide
- Bonbrrin
- Distaxal
- Distoval
- Pharmion
- Telargan
- Celgene
- Kedavon
- Lulamin
- 3-Phthalimidoglutarimide
- Actimid
- Synovir
- Myrin
- (+-)-Thalidomide
- N-Phthalylglutamic acid imide
- Talizer
- (+)-Thalidomide
- (-)-Thalidomide
- Thalidomide Celgene
- l-Thalidomide
- Pro-Bam M
- alpha-Phthalimidoglutarimide
- Talidomide [DCIT]
- Thalidomide-d4
- Talidex
- Talinol
- 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
- thalidomid-
- (S)-Thalidomide
- Thalidomine USP26
- D-Thalidomide
- alpha-N-Phthalylglutaramide
- Thalomid (TM)
- Thalomid (TN)
- (y)-Thalidomide
- Thalidomide Pharmion
- (R)-Thalidomide
- Glutarimide, 2-phthalimido-
- Thalidomide, L-
- Thaled (TN)
- (?)-Thalidomide
- 2,6-Dioxo-3-phthalimidopiperidine
- N-Phthalyl-glutaminsaeure-imid
- Talidomida [INN-Spanish]
- Thalidomidum [INN-Latin]
- NSC-66847
- (R)-(+)-thalidomide
- Nphthaloylglutamimide
- Prestwick_463
- ( -)-Thalidomide
- IMIDAN
- N-(2,6-Dioxo-3-piperidyl)phthalimide
- Sedoval K-17
- alpha-(N-Phthalimido)glutarimide
- K-17
- Thalomid, Thalidomide
- S-(-)-Thalidomide
- .alpha.-Phthalimidoglutarimide
- C13H10N2O4
- Thalidomide (+ and -)
- 4Z8R6ORS6L
- RefChem:6298
- Thalidomide (Standard)
- (A+/-)-Thalidomide
- Pomalidomide Impurity O
- Thalidomide (+ and-)
- CHEMBL468
- Thalidomide (soluble form)
- UNII-4Z8R6ORS6L
- (S)-(-)-thalidomide
- .alpha.-N-Phthalylglutaramide
- DTXSID9022524
- AC1L1KBZ
- AC1Q6FJA
- ENMD 0995
- THALIDOMIDE [MI]
- Prestwick0_000192
- Prestwick1_000192
- Prestwick2_000192
- Prestwick3_000192
- Spectrum2_000707
- Spectrum3_001715
- Spectrum4_001087
- Spectrum5_001791
- Thalidomide [USAN:INN:BAN]
- THALIDOMIDE [INN]
- THALIDOMIDE [JAN]
- (.+/-.)-Thalidomide
- UEJJHQNACJXSKW-UHFFFAOYSA-N
- N-phthal-nu-oylglutamimide
- N-Phthalimidoglutamic acid imide
- MFCD00153873
- THALIDOMIDE [HSDB]
- THALIDOMIDE [USAN]
- D0U7GK
- Thalidomide (JAN/USP/INN)
- UPCMLD-DP139
- HSDB 3586
- THALIDOMIDE [VANDF]
- Thalomid (TN) (Celgene)
- SCHEMBL7581
- CCRIS 8148
- DTXCID402524
- K 17
- Celgene Brand of Thalidomide
- NCIOpen2_003188
- THALIDOMIDE [MART.]
- UNII-TG87FSR590
- Lopac0_001224
- BSPBio_000143
- BSPBio_001156
- BSPBio_003330
- KBioGR_000496
- KBioGR_001474
- KBioGR_002322
- KBioSS_000496
- KBioSS_002324
- Thalidomide (1652500)
- THALIDOMIDE [USP-RS]
- THALIDOMIDE [WHO-DD]
- .alpha.-(N-Phthalimido)glutarimide
- MLS000069353
- NSC66847
- ARONIS24496
- DivK1c_000051
- NSC-527179
- SPECTRUM1503607
- E-217
- EINECS 200-031-1
- SPBio_000893
- SPBio_002064
- N-Phthalyl-glutaminsaeure-imid [German]
- THALIDOMIDE [EMA EPAR]
- Thalidomide [USAN:BAN:INN]
- BPBio1_000159
- CHEBI:9513
- GTPL7327
- orb1310829
- Phthalimide, N-(2,6-dioxo-3-piperidyl)-
- NSC 527179
- SCHEMBL15197560
- SCHEMBL23093380
- SCHEMBL26641645
- UPCMLD-DP139:001
- 2-(2,5-dimethylphenyl)pyridine
- CHEBI:74947
- CTK8B6291
- ERK5-3M14
- HMS500C13
- KBio1_000051
- KBio2_000496
- KBio2_002322
- KBio2_003064
- KBio2_004890
- KBio2_005632
- KBio2_007458
- KBio3_000911
- KBio3_000912
- KBio3_002550
- KBio3_002802
- 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline
- BRN 0030233
- CID5426
- L04AX02
- THALIDOMIDE (AIDS INITIATIVE)
- THALIDOMIDE [ORANGE BOOK]
- cMAP_000022
- IN1061
- N-(2,6-dioxo-3-piperidinyl)phthalimide
- NINDS_000051
- Bio1_000387
- Bio1_000876
- Bio1_001365
- Bio2_000418
- Bio2_000898
- GLXC-07837
- HMS1362J17
- HMS1568H05
- HMS1792J17
- HMS1922E12
- HMS1990J17
- HMS2090O05
- HMS2093G15
- HMS2095H05
- HMS2234C07
- HMS3259C22
- HMS3263F10
- HMS3266F13
- HMS3373E06
- HMS3373G15
- HMS3403J17
- HMS3414F19
- HMS3654A20
- HMS3678F19
- HMS3712H05
- HMS3884I05
- HMS5079O13
- Pharmakon1600-01503607
- THALIDOMIDE [USP MONOGRAPH]
- (+-)-N-(2,6-Dioxo-3-piperidyl)phthalimide
- 3-Phthalimidylpiperidine-2,6-dione
- BCP19772
- CC 4047
- CID:5426
- DRG-0184
- NSC91729
- NSC91730
- Phthalimide,6-dioxo-3-piperidyl)-
- (inverted question mark)-Thalidomide
- 2, 6-Dioxo-3-phthalimidopiperidine
- AI3-50606
- Thalidomide [USAN:USP:INN:BAN:JAN]
- Tox21_110275
- Tox21_300580
- Tox21_501224
- AC-917
- ANW-53225
- BBL023439
- BDBM50070114
- CCG-39878
- EBC-04403
- HY-14658R
- LS-140
- MSK157727
- NA2811
- NCGC00015989-09
- NSC 91730
- NSC-91729
- NSC-91730
- NSC527179
- NSC758479
- STL356025
- UN2811
- ( inverted question mark)-Thalidomide
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-
- AKOS009529198
- C13-H10-N2-O4
- Tox21_110275_1
- WLN: T56 BVNVJ C- DT6VMVTJ
- CS-1084
- DB01041
- FT15648
- J4.101G
- LP01224
- NC00600
- NSC-758479
- RP29207
- SDCCGSBI-0051191.P004
- Thalidomide, 98% - 500mg 500mg
- (+/-)-Thalidomide, >=98%, powder
- 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
- 2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione
- CAS-50-35-1
- IDI1_000051
- IDI1_002173
- KS-00000H64
- (+/-)-Thalidomide - Bio-X trade mark
- n-(2,6-dioxopiperidin-3-yl)phthalimide
- NCGC00015989-03
- NCGC00015989-04
- NCGC00015989-05
- NCGC00015989-06
- NCGC00015989-07
- NCGC00015989-08
- NCGC00015989-10
- NCGC00015989-11
- NCGC00015989-12
- NCGC00015989-13
- NCGC00015989-14
- NCGC00015989-16
- NCGC00015989-17
- NCGC00015989-29
- NCGC00015989-32
- NCGC00024708-02
- NCGC00024708-03
- NCGC00024708-04
- NCGC00024708-05
- NCGC00024708-06
- NCGC00024708-07
- NCGC00024708-08
- NCGC00024708-09
- NCGC00024708-10
- NCGC00024708-11
- NCGC00254343-01
- NCGC00261909-01
- 2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione
- 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
- 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
- AK-91024
- AN-15419
- AS-12367
- BC204656
- BP-30256
- BT164465
- CPD000058524
- HY-14658
- N-(2,6-Dioxopiperidine 3-yl)phthalimide
- NCI60_023904
- SAM002564245
- SC-18573
- SID:53790759
- SMR000058524
- SY052614
- WLN: T56 BVNVJ C- DT6VMVTJ -D
- WLN: T56 BVNVJ C- DT6VMVTJ -L
- (+/-)-N-(2,6-dioxo-3-piperidyl)phthalimide
- M02554
- SBI-0051191.P003
- AB0011813
- AB2000009
- DB-051759
- LS-109463
- Phthalimide,6-dioxo-3-piperidyl)-, (+)-
- Phthalimide,6-dioxo-3-piperidyl)-, (-)-
- TC-141970
- (+/-)-N-(2,6-Dioxo-3-piperidinyl)phthalimide
- AB00052362
- EU-0101224
- NS00009590
- S1193
- ST24027458
- ST51039042
- SW196678-4
- T-144
- T2524
- 5-22-13-00224 (Beilstein Handbook Reference)
- EN300-60005
- isopropyl (3,4-dichlorophenyl)carbamodithioate
- Phthalimide,6-dioxo-3-piperidyl)-, D-(+)-
- Phthalimide,6-dioxo-3-piperidyl)-, L-(-)-
- 2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione
- C07910
- D00754
- J90042
- M-1523
- AB00052362-11
- AB00052362-12
- AB00052362-13
- AB00052362_14
- AB00052362_15
- alphaphthalimidoglutarimide. Nphthaloylglutamimide
- Thalidomide (Immunoprin, Contergan and Thalomid)
- 153T873
- 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-
- D013792
- Q203174
- SR-01000076184
- (+/-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
- 841-67-8
- A1202754
- I06-0197
- Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (-)-
- SR-01000076184-1
- SR-01000076184-3
- SR-01000076184-5
- SR-01000076184-8
- Thalidomide N-(2,6-Dioxopiperidin-3-yl)phthalimide
- BRD-A93255169-001-04-4
- BRD-A93255169-001-06-9
- BRD-A93255169-001-24-2
- BRD-A93255169-001-27-5
- BRD-A93255169-001-28-3
- I14-23643
- Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (+-)-
- Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (.+.)-
- Phthalimide, N-(2,6-dioxo-3-piperidyl)-, L-(-)-
- 2-(2,6-Dioxo-3-piperidinyl)-2H-isoindole-1,3-dione
- 2-[(3S)-2,6-dioxopiperidin-3-yl]isoindole-1,3-dione
- 2614-06-4
- Z905162656
- 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (R)-
- 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (S)-
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (+-)-
- 2-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)glutarimide
- 2-(2,6-dioxoazaperhydroin-3-yl)benzo[c]azoline-1,3-dione
- 1012310-87-0
- 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione #
- Neo
- [(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
- 2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione
- Thalidomide, United States Pharmacopeia (USP) Reference Standard
- 1219177-18-0
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (.+.)-
- 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)-
- 4,5,6,7-tetradeuterio-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
- ( inverted question mark)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
- 1H-ISOINDOLE-1,3(2H)-DIONE, 2-(2,6-DIOXO-3-PIPERIDINYL)-, (+/-)-
- 200-031-1
- 731-40-8
- Thalidomide; 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione; 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline; 3-Phthalimidoglutarimide; Celgene; Contergan; Distaval; K 17; Kevadon; Myrin; N-(2,6-Dioxo-3-piperidyl)phthalimide; N-Phthaloylglutamimide; NSC 527179; NSC 66847; Neurosedyn; Pantosediv; Pharmion; Quetimid; Sauramide; Sedalis; Sedoval; Softenil; Softenon; Suaramide; Synovir; Talimol; Talinol; Thaled; Thalomid; (+/-)-Thalidomide; alpha-(N-Phthalimido)glutarimide; alpha-N-Phthalylglutaramide; alpha-Phthalimidoglutarimide